leadf
logo-loader

NA Proactive news snapshot: PyroGenesis Canada, Lexaria Bioscience, American Battery Metals, Exactus UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Newspapers and laptop
Your daily round-up from the world of Proactive

PyroGenesis Canada Inc (CVE:PYR) (OTCMKTS:PYRNF) announced Wednesday it has completed successfully all torch tests for Rise Energy Technology Center AB and has received final payment from the Swedish company. The contract, originally announced in January 2019, is for a 900-kilowatt plasma torch system, which was won in a competitive bid process. PyroGenesis's 900-kilowatt plasma torch is used to replace fossil fuel burners in the iron ore induration (pelletization) process. Pelletization is the process in which iron ore is concentrated before shipment, thus significantly reducing the cost of transportation.

Lexaria Bioscience Corp (OTCMKTS:LXRP) (CSE:LXX) announced that it has successfully processed its first CBD nanoemulsion for one of its licensed clients using its DehydraTECH technology. The British Columbia company provides emulsion services using DehydraTECH to qualifying clients who want to formulate ready-to-drink beverages containing CBD. Super-concentrated DehydraTECH-enabled liquid nanoemulsion was shipped to the client's production facility for incorporation into its cold-brewed coffee production and bottling line. Lexaria said it was able to process nearly 100,000 20 mg servings of DehydraTECH-empowered CBD concentrate.

American Battery Metals Corporation (OTCMKTS:ABML) announced Wednesday that the company has paid off its convertible notes in order to stave off potential equity dilution and any corresponding dip in share value. "As an emerging growth micro-cap publicly traded company, we had to do what was needed to survive and advance our business,” CEO Doug Cole said in a statement. “With that said, we were grateful to attract funding from institutional convertible notes over the past two years to advance the company to where it is today.”

Exactus Inc (OTCMKTS:EXDI) is calling 2019 “transformational” for the company as it looks to 2020 “to be a breakout year.” In a letter to shareholders on Wednesday, the Florida company said last year it was able to successfully navigate a downbeat year for most of the industry to position itself for growth in 2020. In fact, Exactus told investors it is on track for gross sales in the first quarter to exceed gross sales of the entire 2019 calendar year.

Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, said its board of directors has passed a resolution to issue 1,300,000 warrants to purchase common shares of the company to employees, advisors and consultants. It said each Warrant will entitle the holder to acquire one common share at a price of $0.60 each until March 4, 2025. Of the 1,300,000 Warrants being issued, 600,000 are being issued to replace existing options and 300,000 are being issued to replace existing special warrants of the company held by employees, advisors and consultants.

Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) said Wednesday that it appointed James A Underberg, to its scientific advisory board for its lead drug candidate MAT9001,  an omega-3 fatty acid based composition designed to treat cardiovascular and metabolic conditions such as hypertriglyceridemia. Dr Underberg said he looked forward to playing a very active role in the development of MAT9001, a next-generation omega-3 therapy.

CytoDyn Inc (OTCMKTS:CYDY), a late-stage biotechnology company, said Wednesday that it has treated its first patient with its lead drug leronlimab (PRO 140), in its Phase 2 clinical trial for graft-versus-host disease (GvHD) under the modified trial protocol. Graft-versus-host disease can occur at any time after a transplant. It is a rare condition that typically occurs when donor bone marrow or stem cells attack the recipient.

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) revealed on Wednesday that its corporate clinics business continues to go from strength to strength. The vertically integrated health and life sciences firm runs a network of physician-staffed wellness clinics and patient visits increased by 800% last month (February) versus the same month in 2019.

NetCents Technology Inc (CSE:NC) (OTCMKTS:NTTCF), the cryptocurrency payments specialist, told investors Wednesday that it beat $2 million of monthly processing volume for this month (February), which was a 48% increase on January. "The processing volume for January and February 2020 exceeds the total volume processed in the entirety of 2019, demonstrating the company's continued ridiculous growth and also attaining the 40% monthly growth in processing as projected in May 2019," noted the tech firm.

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) has accepted an invitation to ring the opening bell at the Canadian Securities Exchange (CSE) on Friday. CEO Raza Bokhari, co-founders Anthony Durkacz and Zeeshan Saeed, and other members of the company’s leadership team will represent the pharmaceutical cannabis research company at the CSE Media Centre in Toronto.

Exro Technologies Inc (CSE:XRO) (OTCMKTS:EXROF) will be presenting at the third annual LD Micro Virtual Conference on Wednesday (today) at 2:40pm EST. Exro CEO Sue Ozdemir will be giving the presentation and answering questions from investors. Those interested can access the live presentation on the webcaster website. Exro's technology platform uses advanced control algorithms and new power electronics design to expand the operating parameters of electric motors, to dramatically enhance electric powertrains, increasing efficiency, speed and power, while reducing component size. "We believe Exro will have a dramatic and positive impact on the world's electric motors, unlocking more of the potential within them to make electric motors faster, stronger and greener," said Ozdemir.

Genprex Inc (NASDAQ:GNPX) is taking part in the third annual LD Micro Virtual Conference on Wednesday March 4. The company, a clinical-stage gene therapy company developing treatments for cancer and other serious diseases, will be presenting and taking investor questions at 1:40 pm EST. "We are delighted to be hosting our third virtual event in order to showcase some of the truly unique names in micro-cap," said Chris Lahiji, president of LD Micro. "There are many people and companies who are unable to attend our live events due to any number of reasons, so we are happy to offer an additional way for companies to present to investors without taking a lot of time out of their day-to-day operations. While virtual events will never replace the experience of sitting in the same room as other humans, it is a great format for updating the investor community and getting increased exposure."

Arctic Star Exploration Corp (CVE:ADD) said that, further to its news release dated February 7, 2020, the company has corrected the number of stock options granted on that date from an aggregate of two million stock options to an aggregate of 1,749,000 stock options granted at an exercise price of 8 cents per common share. The company also announced that it has granted an additional 500,000 stock options to a consultant for the purchase of up to 500,000 common shares of the company, with each option exercisable for a period of 5 years at a price of 6 cents per common share.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CytoDyn Inc. named herein, including the promotion by the Company of CytoDyn Inc. in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

FenixOro Gold continues aggressive drill program at their Abriaqui Project...

FenixOro Gold (CSE: FENX-OTCQB: FDVXF) CEO John Carlesso joined Steve Darling from Proactive to bring details about their drilling program that is ongoing at their gold silver and copper project in Colombia. That project is called Abriaqui and sits along a very mineralized belt. Carlesso...

12 hours, 54 minutes ago

6 min read